Bibliography
- Gershater MA, Londahl M, Nyberg P, et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia 2008
- Chow I, Lemos EV, Einarson T.R. Management and prevention of diabetic foot ulcers and infections: a health economic review. Pharmacoeconomics 2008;26(12):1019-35
- Dowd SE, Wolcott RD, Sun Y, et al. Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS ONE 2008;3(10):e3326
- Sharma VK, Khadka PB, Joshi A, et al. Common pathogens isolated in diabetic foot infection in Bir Hospital. Kathmandu Univ Med J (KUMJ) 2006;4(3):295-301
- Dowd SE, Sun Y, Secor PR, et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008;8:43
- Yoga R, Khairul A, Sunita K, Suresh C. Bacteriology of diabetic foot lesions. Med J Malaysia 2006;61(Suppl A):14-6
- Browne AC, Vearncombe M, Sibbald RG. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft. Ostomy Wound Manage 2001;47(10):44-9
- Percival LB. Biofilms and their potential role in wound healing. Wounds 2004;16(7):234-40
- Johnson GM, Lee DA, Regelmann WE, et al. Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun 1986;54(1):13-20
- Shiau AL, Wu CL. The inhibitory effect of Staphylococcus epidermidis slime on the phagocytosis of murine peritoneal macrophages is interferon-independent. Microbiol Immunol 1998;42(1):33-40
- Kim A, Suecof LA, Sutherland CA, et al. In vivo microdialysis study of the penetration of daptomycin into soft tissues in diabetic versus healthy volunteers. Antimicrob Agents Chemother 2008;52(11):3941-6
- Evans RC, Holmes CJ. Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrob Agents Chemother 1987;31(6):889-94
- Costerton JW, Stewart PS, Greenberg EP, et al. Bacterial biofilms: a common cause of persistent infections. Science 1999;284(5418):1318-22
- Skhirtladze K, Hutschala D, Fleck T, et al. Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery. Antimicrob Agents Chemother 2006;50(4):1372-5
- Stemberger A, Grimm H, Bader F, et al. Local Treatment of Bone and Soft Tissue Infections with Collagen-gentamicin Sponge. Eur J Surg 1997;578:17-26
- Reddi AH. Implant stimulated interface reactions during collagenous bone matrix-induced bone formation. J Biomed Mater Res 1985;19:233-9
- Gooi A, Hochman J, Wellman M, et al. Ototoxic effects of single-dose versus 19-day daily-dose gentamicin. J Otolaryngol Head Neck Surg 2008;37(5):664-7
- Ding D, JH, Jin X. Co-adminsitration of ethacrynic acid and various doses of gentamicin produces different models of cochlear damage in chinchilla. ARO ABSTR 2001;#799
- Lipsky BA, Holroyd KJ, Zasloff M. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin Infect Dis 2008;47(12): 1537-45
- Nelson EA, OMeara S, Golder S, et al. Systematic review of antimicrobial treatments for diabetic foot ulcers. Diabet Med 2006;23(4):348-59
- O'Meara SM, Cullum NA, Majid M, Sheldon TA. Systematic review of antimicrobial agents used for chronic wounds. Br J Surg 2001;88(1):4-21